Amanote Research
Register
Sign In
P2.01-58 Demographics, Clinical Characteristics and Treatment Sequencing in Stage III Unresectable NSCLC Patients: A Cancerlinq Cohort
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1112
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
A. Klein
I. Herr
S. Maclachlan
D. Potter
Publisher
Elsevier BV
Related search
P1.15-27 Patient Characteristics, Treatment Patterns and Survival for Unresectable Stage III NSCLC in Ontario, Canada
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.01-91 Treatment Patterns in Patients With Stage IIIB-IV NSCLC in Clinical Practice: Retrospective Analysis of a UK Trust Database
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-88 Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFRm-Positive Stage III NSCLC (LAURA)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
MA05.02 PACIFIC Subgroup Analysis: Pneumonitis in Stage III, Unresectable NSCLC Patients Treated With Durvalumab vs. Placebo After CRT
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
OA01.07 Updated Results of a Phase II Trial of Concurrent Chemoradiation With Consolidation Pembrolizumab in Patients With Unresectable Stage III NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.17-04 Curative Intent Treatment for Stage III NSCLC in England
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Demographics, Clinical Disease Characteristics, and Quality of Life in a Large Cohort of Psoriasis Patients With and Without Psoriatic Arthritis
Clinical, Cosmetic and Investigational Dermatology
Dermatology
MA05.01 E6508: Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Unresectable Stage III NS-NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.01-113 Prognostic Roles of Neoadjuvant and Adjuvant Chemotherapy for Treating Patients With Operable Stage III-N2 Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary